Pharmacokinetic Study of Polidocanol Endovenous Microfoam (PEM)
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
Varicose veins are enlarged, noticeably bulging veins, which commonly occur in the legs and
may cause discomfort. In this study, patients with varicose veins in the legs will be
participating. The purpose of this research study is to evaluate the pharmacokinetic profile
of two different doses of an investigational drug, Polidocanol Endovenous Microfoam (PEM), an
investigational treatment for varicose veins.
Phase:
Phase 1
Details
Lead Sponsor:
Boston Scientific Corporation BTG International Inc.